These results highlight the significant regulatory role of S100A16 on the PI3K/AKT signaling pathway in modulating the impact of SPDEF. The findings shed new light on the molecular basis of pancreatic cancer. This evidence concerns the gene SPDEF and familial pancreatic carcinoma.